Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ACLX - Arcellx, Inc.
Market Cap 1.64B P/E - EPS this Y -15.60% Ern Qtrly Grth -
Income -50.54M Forward P/E -11.03 EPS next Y -25.30% 50D Avg Chg -6.00%
Sales 131.66M PEG -0.45 EPS past 5Y - 200D Avg Chg 9.00%
Dividend N/A Price/Book 5.39 EPS next 5Y 69.30% 52W High Chg -30.00%
Recommedations 1.60 Quick Ratio 5.35 Shares Outstanding 53.50M 52W Low Chg 119.00%
Insider Own 12.81% ROA -6.71% Shares Float 34.70M Beta 0.24
Inst Own 91.88% ROE -12.63% Shares Shorted/Prior 3.87M/3.77M Price 34.20
Gross Margin 100.00% Profit Margin -38.39% Avg. Volume 563,691 Target Price 80.57
Oper. Margin -40.27% Earnings Date - Volume 436,561 Change 0.06%
Healthcare | Biotechnology | United States
About Arcellx, Inc.

Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company's lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory multiple myeloma (rrMM). It also develops ACLX-001, a product candidate in Phase 1 clinical trials targeting BCMA to treat rrMM; and ACLX-002, which is in Phase 1 clinical trials that targets CD123 for treating relapsed or refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). In addition, the company's preclinical product includes ACLX-003 for the treatment of AML and MDS. Further, it focuses on the development of product candidates for solid tumor programs. It has a strategic alliance with Kite Pharma, Inc. to co-develop and co-commercialize anitocabtagene autoleucel. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Arcellx, Inc. News
05/12/24 Arcellx First Quarter 2024 Earnings: Beats Expectations
05/10/24 Arcellx Inc (ACLX) Q1 2024 Earnings: Narrower Losses and Revenue Surge
05/10/24 Kite and Arcellx prepare to launch Phase III multiple myeloma trial
05/09/24 Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates
05/09/24 Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
05/09/24 Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
05/09/24 Arcellx Provides First Quarter 2024 Financial Results
05/09/24 Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine
05/07/24 Arcellx to Participate in Two Upcoming Investor Conferences
04/23/24 Should You Be Bullish on Arcellx (ACLX)?
04/04/24 Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference
04/04/24 How Arcellx (ACLX) Stock Stands Out in a Strong Industry
03/29/24 Dell, Dun & Bradstreet, Diebold Nixdorf, and More Stocks See Action From Activist Investors
03/28/24 Insiders Are Dumping These 10 Healthcare Stocks
03/27/24 Insider Sell: Arcellx Inc's Chief Medical Officer Christopher Heery Disposes of 46,815 Shares
03/20/24 Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
03/02/24 Earnings Update: Arcellx, Inc. (NASDAQ:ACLX) Just Reported And Analysts Are Boosting Their Estimates
02/29/24 Arcellx to Participate at the TD Cowen 44th Annual Health Care Conference
02/28/24 Arcellx, Inc. (ACLX) Q4 Earnings and Revenues Surpass Estimates
02/28/24 Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights
ACLX Chatroom

User Image Thestocktraderhubzee Posted - 5 days ago

WATCHLIST MAY 14 2024.. $SWIM Barclays Maintains Equal-Weight on Latham Group, Raises Price Target to $4 $TIXT Barclays Maintains Equal-Weight on TELUS Intl, Lowers Price Target to $7 $NKTX HC Wainwright & Co. Maintains Buy on Nkarta, Raises Price Target to $23 $CRBU HC Wainwright & Co. Reiterates Buy on Caribou Biosciences, Maintains $24 Price Target $ACLX HC Wainwright & Co. Maintains Buy on Arcellx, Lowers Price Target to $80

User Image Stocksrunner Posted - 1 week ago

📊Key Technical Indicators Update: $ACLX, $DCBO, $AMR, and $PBF slipped below their 200-day moving averages, indicating possible bearish trends. 📉💔

User Image Stock_Titan Posted - 1 week ago

$GILD $ACLX Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program https://www.stocktitan.net/news/GILD/kite-and-arcellx-continue-momentum-with-advances-in-anito-cel-ga2mar63tq6o.html

User Image Stock_Titan Posted - 1 week ago

$ACLX $GILD Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program https://www.stocktitan.net/news/ACLX/arcellx-and-kite-continue-momentum-with-advances-in-anito-cel-iwhqjy25gvt1.html

User Image Stock_Titan Posted - 1 week ago

$ACLX Arcellx Provides First Quarter 2024 Financial Results https://www.stocktitan.net/news/ACLX/arcellx-provides-first-quarter-2024-financial-t5tuhtqagy0n.html

User Image insiderbuyingselling Posted - 2 weeks ago

$ACLX new insider selling: 18168 shares. http://insiderbuyingselling.com/?t=ACLX

User Image insiderbuyingselling Posted - 1 month ago

$ACLX new insider selling: 9402 shares. http://insiderbuyingselling.com/?t=ACLX

User Image Quantumup Posted - 1 month ago

BMO Capital $LEGN Outperform/$90: "1Q24 Sales Missed Consensus by ~8%; We Don't see any Long-Term Impact" BMO expects the 2L approval2 sig'ly expand the addressable pop/demand +w/ mfg'g scaling will enable Carvykti sales2meet/beat '24 cons expys (~$1B): $ACLX $jnj $gild $tsvt bmy

User Image svb64 Posted - 1 month ago

$ACLX where is this going to land?

User Image Stock_Titan Posted - 1 month ago

$ACLX Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference https://www.stocktitan.net/news/ACLX/arcellx-to-participate-in-the-23rd-annual-needham-virtual-healthcare-xb5jsp4n57mu.html

User Image InsiderPeek Posted - 1 month ago

$ACLX CEO Elghandour Rami sold 23.1k shares for $1.5 millions (ownership down 25.0%) insiderpeek.com/company/ACLX

User Image insiderbuyingselling Posted - 03/26/24

$ACLX new insider selling: 46815 shares. http://insiderbuyingselling.com/?t=ACLX

User Image insiderbuyingselling Posted - 03/25/24

$ACLX new insider selling: 504263 shares. http://insiderbuyingselling.com/?t=ACLX

User Image Stock_Titan Posted - 03/20/24

$ACLX Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference https://www.stocktitan.net/news/ACLX/arcellx-to-participate-at-the-h-c-wainwright-2nd-annual-cell-therapy-510f6hq5ceyj.html

User Image insiderbuyingselling Posted - 2 months ago

$ACLX new insider selling: 6825 shares. http://insiderbuyingselling.com/?t=ACLX

User Image Thestocktraderhubzee Posted - 2 months ago

$ACLX Needham Maintains Buy on Arcellx, Raises Price Target to $81

User Image Doorkey Posted - 2 months ago

$ACLX $$$$

User Image Quantumup Posted - 2 months ago

Truist⬆️PT $ACLX $87 was $57/Buy Truist is increasingly confident that Arcellx's CAR-T Anito-cel, has Best-in-Class pot, after reflecting on recently presented data for Carvykti -- combo'd w/ $GILD P'ship, Truist is optimistic Anito-cel can take a strong mkt position. $legn $jnj

User Image Stocksrunner Posted - 2 months ago

📉 Analyst Downgrades Alert! 🚨📉 1️⃣ $AM Antero Midstream hits the analyst target price. Get the lowdown on the recent downgrade and its implications. 2️⃣ $ACLX Arcellx Inc crosses the average analyst target, triggering a downgrade. Find out the reasons behind this valuation shift. 3️⃣ $ALV Autoliv Inc surpasses the analyst target price. Explore the recent downgrade and its impact on Autoliv. 4️⃣ $CERT Certara Inc reaches the analyst target price. Delve into the details of the downgrade and its market implications. 5️⃣ $CIEN Ciena Corp crosses the average analyst target, prompting a downgrade. Uncover the reasons behind this valuation adjustment. 📉 Stay informed on these market movers! https://stocksrunner.com/home

User Image Stock_Titan Posted - 02/29/24

$ACLX Arcellx to Participate at the TD Cowen 44th Annual Health Care Conference https://www.stocktitan.net/news/ACLX/arcellx-to-participate-at-the-td-cowen-44th-annual-health-care-hylviodqz0a2.html

User Image DonCorleone77 Posted - 02/28/24

$ACLX Arcellx reports Q4 revenue $63.1M, consensus $15.68M Q4 net income was $20.5M vs. ($39.0M) last year. As of December 31, 2023, Arcellx had cash, cash equivalents, and marketable securities of $729.2M, which Arcellx expects to fund its operations into 2027 "In 2023, our team built upon the momentum that has propelled Arcellx forward over the past two years," said CEO Rami Elghandour. "We expanded our partnership with Kite, through a $200M investment, extending our cash runway into 2027 and deepened our collaboration by expanding into lymphomas. Additionally, we presented robust long-term data from our Phase 1 expansion study of anito-cel at the 65th ASH Annual Meeting..This year is poised to be another year of meaningful progress for our organization. We are focused on completing enrollment in the iMMagine-1 trial, initiating our clinical trial in earlier lines of multiple myeloma, and completing the technical transfer to Kite...."

User Image Stock_Titan Posted - 02/28/24

$ACLX Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights https://www.stocktitan.net/news/ACLX/arcellx-provides-fourth-quarter-and-year-end-2023-financial-results-ucm286q03uzx.html

User Image TickerDD_com Posted - 02/21/24

From 2/16/2024, looking back across 22 Month-Ends for ACLX, Percentage Change of Average Monthly Price had More Positives (77%) while Percentage Change of Average Monthly Volume had All Positives (100%) $ACLX #ACLX #ACLXStock #TickerDD #ACLXPrice https://www.youtube.com/watch?v=H7g4XDiLsQI

User Image insiderbuyingselling Posted - 3 months ago

$ACLX new insider selling: 10111 shares. http://insiderbuyingselling.com/?t=ACLX

User Image TalkMarkets Posted - 3 months ago

Decoding Bearish Analog And The Warning Signs You Can't Ignore $ACLX $SPX $SRPT https://talkmarkets.com/content/stocks--equities/decoding-bearish-analog-and-the-warning-signs-you-cant-ignore?post=430831&userid=166882

User Image popculture Posted - 3 months ago

$ACLX

User Image StockInvest_us Posted - 3 months ago

Signal alert: $ACLX - Overbought Trend Short (Overvalued) https://stockinvest.us/l/PO41dTkTtu

User Image VirmoMopire Posted - 01/30/24

$ACLX Looks like it is making some moves today! 📈

User Image szaman Posted - 01/28/24

$ACLX chart via @MarketSmith #IBDpartner. Biotech IPO breaking out again with volume. https://bit.ly/424cWtr

User Image GuerillaStockTrading Posted - 01/28/24

Arcellx $ACLX A Promising Biotech Gem SWEET LOOKING ASCENDING TRIANGLE BREAKOUT, THIS NAUGHTY GIRL COULD RUN https://www.guerillastocktrading.com/arcellx-a-promising-biotech-gem/

Analyst Ratings
Stifel Buy May 15, 24
Evercore ISI Group Outperform May 14, 24
HC Wainwright & Co. Buy May 13, 24
Needham Buy May 10, 24
Needham Buy May 7, 24
Needham Buy Apr 11, 24
Needham Buy Mar 18, 24
Stifel Buy Mar 14, 24
Morgan Stanley Overweight Mar 7, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Heery Christopher Chief Medical Office.. Chief Medical Officer Jan 02 Option 0.00 16,519 25,457 01/04/24
Gilson Michelle Chief Financial Offi.. Chief Financial Officer Jan 02 Option 0.00 15,339 24,824 01/04/24
Elghandour Rami See Remarks See Remarks Jan 02 Option 0.00 53,097 89,266 01/04/24
Heery Christopher Chief Medical Office.. Chief Medical Officer Aug 04 Sell 35.38 3,000 106,140 7,795 08/07/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Aug 04 Option 15 3,000 45,000 10,795 08/07/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Jul 03 Sell 31.75 3,000 95,250 7,795 07/05/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Jul 03 Option 15 3,000 45,000 10,795 07/05/23
Elghandour Rami See Remarks See Remarks May 31 Sell 44.2688 2,600 115,099 36,169 06/02/23
Gilson Michelle Chief Financial Offi.. Chief Financial Officer May 23 Sell 42.29 14,704 621,832 9,485 05/25/23
Gilson Michelle Chief Financial Offi.. Chief Financial Officer May 23 Option 0 22,428 24,189 05/25/23
Carroll Jill Director Director May 11 Sell 45.58 638,417 29,099,047 2,828,394 05/15/23
SR ONE CAPITAL MANAGEMENT, LLC 10% Owner 10% Owner May 11 Sell 45.58 1,012,833 46,164,928 1,658,780 05/15/23
Heery Christopher Chief Medical Office.. Chief Medical Officer May 05 Sell 45.0017 1,200 54,002 10,492 05/08/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Apr 03 Sell 30.9 3,000 92,700 15,589 04/04/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Apr 03 Option 15 3,000 45,000 18,589 04/04/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Feb 07 Sell 30.77 6,966 214,344 15,589 02/09/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Feb 07 Option 0 22,555 22,555 02/09/23
Elghandour Rami See Remarks See Remarks Feb 07 Sell 30.77 31,442 967,470 38,769 02/09/23
Elghandour Rami See Remarks See Remarks Feb 07 Option 0 70,211 70,211 02/09/23
SANDELL SCOTT D 10% Owner 10% Owner Dec 23 Sell 31.67 390 12,351 12/27/22
SANDELL SCOTT D 10% Owner 10% Owner Dec 20 Sell 30.74 179 5,502 12/22/22
New Enterprise Associates 15,... 10% Owner 10% Owner Jun 21 Buy 16.00 312,500 5,000,000 6,745,262 06/23/22
SR ONE CAPITAL MANAGEMENT, LLC 10% Owner 10% Owner Feb 08 Buy 15 1,666,667 25,000,005 2,033,196 02/10/22
New Enterprise Associates 15,... 10% Owner 10% Owner Feb 08 Buy 15 1,583,333 23,749,995 6,432,762 02/09/22
Carroll Jill Director Director Feb 08 Buy 15 1,666,667 25,000,005 2,033,196 02/09/22
Novo Holdings A/S 10% Owner 10% Owner Feb 08 Buy 15 833,333 12,499,995 4,016,878 02/09/22